Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01281072
  4. Details
NCT01281072 Clinical Trial

Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Giving a Vaccination in Three Months Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT01281072
Other study ID # 911-DIAPEP277
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received January 20, 2011
Last updated January 20, 2011

Study information
Verified date January 2011
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

Open label study to evaluate long term treatment effect of diapep277.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

1. patient that completed 901 and 910 study.

Exclusion Criteria:

1. cpeptide<0.2

Study Design

Intervention Model: Single Group Assignment

Related Conditions & MeSH terms

  • Giving a Vaccination in Three Months

Intervention

Other:
• vaccine

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Hadassah Medical Organization DIABETES UNIT

Outcome
Type Measure Description Time frame Safety issue
Primary c peptide reserve